Folinic Acid.
Alternative folate form. Cerebral folate support. A fully reduced folate that steps straight into the cell one-carbon pool, feeding DNA building and the methylation cycle without the reduction step folic acid needs first.
Reviewed March 2026
- Category
- Vitamin
- Also filed under
- FolateAlternativeAutism
What Folinic Acid is, and what it does.
- Does it work
- Suits people who want a reduced folate that is not the methyl form, and anyone a clinician has pointed to this one. Everyday folate needs are met by the simpler forms too.
- How much to take
- Start with 200mcg to 800mcg a day, the maintenance band that keeps the cell folate pool supplied. The 2,000mcg seen in trials is a research condition, not a daily target.
- Time to feel it
- Blood folate rises within hours and red cell folate settles at a new level over roughly two to three months. This shows up as a lab value rather than a sensation.
- The first dose
- Blood folate is up within hours as it joins the one-carbon pool. Day one is a plasma change rather than something you would sense.
- With regular use
- Weeks of daily use raise and hold red cell folate, keeping one-carbon supply steady for DNA synthesis, methylation and homocysteine recycling.
- How well tolerated
- Well tolerated at everyday amounts. Any folate can obscure a low B12 reading on a blood count, so keep B12 alongside it and check with your doctor before high intakes.
- How it feels
- Not something you sense. People correcting a low folate reading often describe steadier weeks; the dependable measure is the folate panel.
- The overlooked benefit
- It bypasses dihydrofolate reductase but still passes through MTHFR, so it is not the way around that enzyme it often gets described as. Methylfolate is the form that does that.
200 to 800mcg a day is where Folinic Acid works.
Source: Leucovorin prescribing information; Frye et al., Mol Psychiatry, 2018
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 15 human trials.
- folate status in bloodRandomised trial
- homocysteine already in the normal rangeRandomised trial
- folate delivery to the central nervous systemNarrative review
- one-carbon supply for DNA synthesis in dividing cellsNarrative review
Questions people ask about Folinic Acid.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
5-formyltetrahydrofolate feeds back into the tetrahydrofolate pool that can be methylated, while 5-methyltetrahydrofolate serves the methylation branch directly. Together they cover both the purine and thymidylate side and the methylation side of the folate cycle.
Folinic acid is an already-reduced folate that enters the same tetrahydrofolate pool as any other folate form. Label lines for both count toward one intake.
Folinic acid is already reduced and skips the dihydrofolate reductase step that folic acid depends on, yet the two still compete for the same intestinal and cellular folate transporters. Dosing both gives one entry route two claimants.
Tetrahydrofolate derived from folinic acid can be methylated and then must hand its methyl group to cobalamin at methionine synthase. Without B12 that traffic backs up in the methylated form.
Serine hydroxymethyltransferase, which loads one-carbon units onto tetrahydrofolate, is a pyridoxal 5-phosphate enzyme, and B6 also runs the transsulfuration exit for homocysteine. Folate and B6 act on the same two-branch pathway.
Converting the tetrahydrofolate that folinic acid supplies into 5-methyltetrahydrofolate needs the FAD-dependent MTHFR. Riboflavin status therefore sets how much of the folinic acid reaches the methylation branch.
Serine transfers its beta-carbon to tetrahydrofolate, which is exactly the carrier folinic acid replenishes. Carrier and cargo have to be present together.
The glycine cleavage system loads a one-carbon unit onto tetrahydrofolate and releases the rest as carbon dioxide and ammonia. Glycine both feeds and draws from the folate pool folinic acid supports.
Choline's oxidation product betaine offers a folate-independent methyl route, so the two pools cover for one another. Low folate raises the pull on choline and the same is true in the other direction.
Betaine remethylates homocysteine without needing folate or B12, running alongside the folate-dependent route. Together they give the methylation cycle two independent inputs.
Intestinal folate conjugase and methionine synthase both need zinc, so zinc status affects how folates are handled. High folate intakes also interact with zinc absorption, which makes this two-directional.
Folinic acid supplies one-carbon units for the thymidylate synthesis that dividing erythroid cells need, while iron is placed into heme. Normal red blood cell formation depends on both.
Reduced folates are oxygen-sensitive and ascorbate slows their breakdown in solution and in the gut. The benefit is chemical stability, not metabolic activation.
Dihydrofolate reductase and methylenetetrahydrofolate reductase both spend NADPH, which is built on the niacin-derived nucleotide pool. Folinic acid enters the folate cycle downstream of dihydrofolate reductase, but the onward reductive steps still draw on that pool. Poor niacin status slows the reductive side of one-carbon metabolism regardless of folate supply.
Serine hydroxymethyltransferase is a pyridoxal-5-phosphate enzyme and is the main route that loads a one-carbon unit onto tetrahydrofolate. Folinic acid supplies the folate backbone; the active B6 form supplies the enzyme that fills it. The two sit one step apart in the same cycle.
Methionine is the product of homocysteine remethylation, the reaction that consumes 5-methyltetrahydrofolate. A high methionine load raises S-adenosylmethionine, which allosterically inhibits methylenetetrahydrofolate reductase and pushes folate units away from the methylation branch. Intake of one changes where the other is spent.
Histidine catabolism passes through formiminoglutamate, which hands its formimino group to tetrahydrofolate. This is the reaction behind the classic FIGLU test of folate status. A histidine load therefore draws on the same folate pool folinic acid replenishes.
Endogenous creatine synthesis is one of the largest single consumers of S-adenosylmethionine methyl groups. Supplying creatine directly reduces that methylation demand, which spares the folate-dependent remethylation cycle. The relationship is mechanistic and has been examined mainly through homocysteine, which is a marker rather than an outcome.
S-adenosylmethionine is the downstream product of the cycle folate feeds and is also its regulator, inhibiting methylenetetrahydrofolate reductase when it is plentiful. Supplying it directly changes the pull on folate-dependent remethylation. The two are the same cycle read from opposite ends.
Homocysteine sitting at the junction of the folate cycle can either be remethylated to methionine or committed down transsulfuration to cysteine and glutathione. N-acetylcysteine supplies cysteine directly and eases that pull. This shifts the balance between the two exits rather than adding folate.
Cysteine is the transsulfuration product of homocysteine and exerts feedback on that branch. Adequate cysteine intake reduces the need to commit homocysteine downstream. Folate and B12 govern the other exit, so the two work on the same junction from different sides.
Several bifidobacteria synthesise folates de novo and release them into the colonic lumen, where some is absorbed. That microbial contribution runs alongside an oral reduced folate rather than replacing it. The size of the contribution in humans is not well quantified.
Selected Lactobacillus plantarum strains are folate producers and are used as such in fermented foods. Their output adds to the luminal folate pool. Strain matters here, since folate production is not a species-wide trait.
Inulin selectively feeds bifidobacteria, some of which are folate producers. Expanding that population is the indirect route by which a prebiotic could raise colonic folate. The chain has several steps and each one is a place the effect could disappear.
EGCG inhibits dihydrofolate reductase in laboratory assays, which is one of the enzymes that keeps folates in their reduced usable state. Folinic acid is already a reduced folate and bypasses that specific step, so the interaction matters more for folic acid than for folinic. This is cell and enzyme work, not a human interaction study.
Carnitine biosynthesis and the methylated compounds around it draw on S-adenosylmethionine, the same methyl currency the folate cycle regenerates. Supplying carnitine reduces one small methylation demand. The effect is modest next to creatine and phosphatidylcholine synthesis.
Nothing specific on file for Folinic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Folinic Acid actually does.
Folinic acid is 5-formyltetrahydrofolate, a fully reduced folate that enters the cellular folate pool without needing dihydrofolate reductase to reduce it first.
Inside the cell folinic acid is converted through 5,10-methenyltetrahydrofolate to 5,10-methylenetetrahydrofolate, the branch point that feeds thymidylate synthesis, purine synthesis and the methylation cycle.
Methylenetetrahydrofolate reductase converts that branch-point folate to 5-methyltetrahydrofolate, which hands its methyl group to homocysteine through the vitamin B12-dependent methionine synthase reaction.
Folinic acid enters the cycle upstream of the MTHFR step, so unlike methylfolate it still passes through that enzyme; it bypasses dihydrofolate reductase, not MTHFR.
Where Folinic Acid comes from.
It starts as ordinary folic acid, which chemists then reduce and add a small formyl group to. That extra group is what keeps the fragile reduced folate stable in a capsule. The end result is a salt powder, not a plant extract.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Production starts from synthetic folic acid, itself built from a pterin, para-aminobenzoic acid and glutamate.
Folic acid is chemically or catalytically reduced across the pterin ring to tetrahydrofolate. This reduction is the step the body would otherwise perform with dihydrofolate reductase.
A formyl group is added at the N5 position to give 5-formyltetrahydrofolate. The formyl group is what makes the molecule stable enough to handle, since unsubstituted tetrahydrofolate oxidises quickly in air.
The acid is converted to its calcium or sodium salt and crystallised. Where the single 6S diastereomer is wanted, a resolution or an enzymatic step is inserted here.
Chromatography sets the folinate content and, for levofolinate material, confirms the 6S to 6R ratio.
Blended with carriers and often protected from light and moisture, since reduced folates oxidise on exposure.
Getting Folinic Acid from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- The authors pooled trials of folic and folinic acid given alongside low-dose methotrexate and reported on tolerability and on whether the supplementation changed the drug's measured effect.Systematic review. Prey S et al., 2009 (British Journal of Dermatology). PMID 18945303 ↗
- Short-term folinic acid supplementation improved flow-mediated vascular reactivity, which is a vascular marker measured by ultrasound and not a clinical event.Randomised trial. Grigoletti SS et al., 2013 (Nutrition). PMID 23660169 ↗
- Folinic acid supplementation combined with aerobic exercise improved measured vascular reactivity; the design pairs two interventions, so the folinic acid contribution cannot be isolated from the exercise.Randomised trial. Grigoletti SS et al., 2018 (HIV Clinical Trials). PMID 29400626 ↗
- Folinic acid supplementation was examined for its effect on plasma homocysteine concentration in newborns; homocysteine is a metabolic marker of one-carbon status, not an outcome.Randomised trial. Hogeveen M et al., 2010 (European Journal of Clinical Nutrition). PMID 20823897 ↗
- Rumen-protected folate supplementation altered one-carbon metabolism markers and steroid-related measures in the animals studied; the compound tested was folic acid rather than folinic acid.Animal study. Yang Z et al., 2025 (Animal Reproduction Science). PMID 40373383 ↗
- A bioactive folate reduced markers of elevated liver fat induced by valproic acid in the animals studied; this is a rodent model and does not transfer to human supplementation.Animal study. Ashraf H et al., 2026 (BMC Gastroenterology). PMID 42374202 ↗
These are the studies our verdict leans on, chosen from the 6 we read for Folinic Acid. The full linked list is below.
The studies, linked.
4 sources behind our Folinic Acid verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPancreatic Adenocarcinoma Signature Stratification for TreatmentClinicalTrials.gov ↗PHASE2 · 150 participants · Completed
- Clinical trialRANDOMIZED PHASE II STUDY OF A WEEKLY 24H-INFUSION OF HIGH-DOSE 5-FU PLUS OR MINUS FOLINIC ACID (HD-FU/FA) VERSUS HD-FU/FA PLUS BIWEEKLY CISPLATIN VERSUS FAMTX (5-FU/ADRIAMYCIN/METHOTREXATE) IN ADVANCED GASTRIC CANCER, AN EORTC/AIO INTERGROUP TRIALClinicalTrials.gov ↗PHASE2 · 135 participants · Completed
- Clinical trialPhase I Trial of huA33 Plus 5-fluorouracil (5-FU), Leucovorin and Oxaliplatin in Patients With Metastatic Colorectal CancerClinicalTrials.gov ↗PHASE1 · 20 participants · Completed
- Clinical trialA Phase 1 Open-Label Study of PF-07934040 as a Single Agent and in Combination With Other Targeted Agents in Participants With Advanced Solid Tumors Harboring Mutations in the KRAS GeneClinicalTrials.gov ↗PHASE1 · 64 participants · Active not recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 29,382 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Folinic Acid is, not how risky it is. A report is not proof Folinic Acid caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.